Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
55,996,442
-
Share change
-
+1,982,957
-
Total reported value
-
$194,308,882
-
Put/Call ratio
-
110%
-
Price per share
-
$3.47
-
Number of holders
-
108
-
Value change
-
+$5,621,581
-
Number of buys
-
50
-
Number of sells
-
50
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2023
As of 30 Sep 2023 SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) had 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,996,442 shares of stock of the company.
Largest 10 holders included BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Rubric Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Verition Fund Management LLC, Holocene Advisors, LP, and BAILLIE GIFFORD & CO.
This table shows 108 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.